Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Botting

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Rapid Communications in Mass Spectrometry : RCM|November 21, 2000
The use of the slow crystallisation method to improve matrix-assisted laser desorption/ionisation time-of-flight signals for larger proteinsC H Botting
The New Zealand Medical Journal|July 13, 1994
Paracetamol and childrenC H Botting
The New Zealand Medical Journal|September 22, 1995
The challenge of the continuing effects of poliomyelitis in New ZealandC H Botting, J Chetwynd
Biotechniques|September 1, 1995
Reporter enzyme-nitrilotriacetic acid-nickel conjugates: reagents for detecting histidine-tagged proteinsC H Botting, R E Randall
Nucleic Acids Research|June 22, 1999
Characterisation of the adenovirus preterminal protein and its interaction with the POU homeodomain of NFIII (Oct-1)C H Botting, R T Hay
Genomics|July 29, 2008
Bayesian biomarker identification based on marker-expression proteomics dataM Bhattacharjee, C H Botting, M J Sillanpää
The New Zealand Medical Journal|May 24, 1989
The use of a simulated patient to assess clinical practice in the management of a high risk asthmaticJ J O'Hagan, C H Botting, L J Davies
The New Zealand Medical Journal|September 23, 1987
General practitioner fees: the effect of an additional 10% goods and services taxL J Toop, S J Chetwynd, C H Botting
Nucleic Acids Research|April 4, 1998
Adenovirus DNA polymerase: domain organisation and interaction with preterminal proteinE J Parker, C H Botting, A Webster, et al.
Vaccine|April 9, 1999
Novel modifications to the C-terminus of LTB that facilitate site-directed chemical coupling of antigens and the development of LTB as a carrier for mucosal vaccinesA M O'Dowd, C H Botting, B Precious, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Rapid Communications in Mass Spectrometry : RCM|November 21, 2000
The use of the slow crystallisation method to improve matrix-assisted laser desorption/ionisation time-of-flight signals for larger proteinsC H Botting
The New Zealand Medical Journal|July 13, 1994
Paracetamol and childrenC H Botting
The New Zealand Medical Journal|September 22, 1995
The challenge of the continuing effects of poliomyelitis in New ZealandC H Botting, J Chetwynd
Biotechniques|September 1, 1995
Reporter enzyme-nitrilotriacetic acid-nickel conjugates: reagents for detecting histidine-tagged proteinsC H Botting, R E Randall
Nucleic Acids Research|June 22, 1999
Characterisation of the adenovirus preterminal protein and its interaction with the POU homeodomain of NFIII (Oct-1)C H Botting, R T Hay
Genomics|July 29, 2008
Bayesian biomarker identification based on marker-expression proteomics dataM Bhattacharjee, C H Botting, M J Sillanpää
The New Zealand Medical Journal|May 24, 1989
The use of a simulated patient to assess clinical practice in the management of a high risk asthmaticJ J O'Hagan, C H Botting, L J Davies
The New Zealand Medical Journal|September 23, 1987
General practitioner fees: the effect of an additional 10% goods and services taxL J Toop, S J Chetwynd, C H Botting
Nucleic Acids Research|April 4, 1998
Adenovirus DNA polymerase: domain organisation and interaction with preterminal proteinE J Parker, C H Botting, A Webster, et al.
Vaccine|April 9, 1999
Novel modifications to the C-terminus of LTB that facilitate site-directed chemical coupling of antigens and the development of LTB as a carrier for mucosal vaccinesA M O'Dowd, C H Botting, B Precious, et al.
Pageof 2